Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
Department of Endocrinology, Shenzhen Children's Hospital, Shenzhen, 518038, China.
Orphanet J Rare Dis. 2021 Oct 9;16(1):416. doi: 10.1186/s13023-021-02039-1.
46, XY disorders of sex development (46, XY DSD) are congenital disorders with 46, XY chromosomal karyotype but inconsistent gonadal/phenotypic sex. One of the biggest concerns for parents and clinicians is the gender assignment. However, there is no standard uniform of care nor consensus at present. We sought to evaluate the current treatment's rationality and provide a reference basis for the gender reassignment in 46, XY DSD patients with a specific diagnosis.
We conducted a cross-sectional survey of gender role with the Pre-school Activities Inventory (PSAI), the Children's Sex Role Inventory (CSRI) in 46, XY DSD patients and set up control groups comparison. Psychiatrist assessed gender dysphoria in patients ≥ 8-year-old with the criteria of diagnostic and statistical manual of mental disorders, 5th edition (DSM-5).
A total of 112 responders of 136 patients participated in this study (82.4%, aged 2-17.8 years, median age: 4-year-old). The follow-up period was from 6 months to 10 years (median: 2 years). Twenty-five females were reassigned to the male gender after a specific diagnosis (16/25 (64%) in 5 alfa-reductase-2 deficiency (5α-RD2), 5/25 (20%) in partial androgen insensitivity syndrome (PAIS), 4/25 (16%) in NR5A1gene mutation). Male gender assignment increased from 55.3 (n = 62) to 77.7% (n = 87). The median PSAI score was similar to the control males in 5α-RD2, PAIS, and NR5A1 gene mutation groups (p > 0.05); while identical to the control females in complete androgen insensitivity syndrome (CAIS) and CYP17A1 gene mutation groups (p > 0.05). PSAI score of children raised as male was higher than those of CAIS and CYP17A1 groups raised as female (p < 0.05). CSRI scale showed no statistical differences in the consistency of gender roles and reassigned gender between 46, XY DSD patients and control groups (p > 0.05). None of the patients over 8-year-old (n = 44) had gender dysphoria.
The reassigned gender in 46, XY DSD patients is consistent with their gender role during early childhood. None of them had gender dysphoria. The molecular diagnosis, gonadal function, and the gender reassignment are congruent within our Chinese cohort. Long-term follow-up and more evaluation are still required.
46,XY 性发育障碍(46,XY DSD)是一种先天性疾病,具有 46,XY 染色体核型,但性腺/表型性别不一致。父母和临床医生最关心的问题之一是性别分配。然而,目前没有标准的统一护理,也没有共识。我们试图评估当前治疗的合理性,并为特定诊断的 46,XY DSD 患者的性别重新分配提供参考依据。
我们对 46,XY DSD 患者进行了学前活动量表(PSAI)和儿童性别角色量表(CSRI)的性别角色横断面调查,并设立了对照组进行比较。精神病医生根据精神障碍诊断与统计手册,第五版(DSM-5)的标准评估年龄≥8 岁的患者的性别焦虑症。
共有 136 例患者中的 112 例(82.4%,年龄 2-17.8 岁,中位年龄:4 岁)参加了这项研究。随访时间为 6 个月至 10 年(中位:2 年)。25 名女性在特定诊断后被重新分配为男性(5α-RD2 中 16/25(64%),PAIS 中 5/25(20%),NR5A1 基因突变中 4/25(16%))。男性分配比例从 55.3%(n=62)增加到 77.7%(n=87)。5α-RD2、PAIS 和 NR5A1 基因突变组的 PSAI 评分中位数与对照组男性相似(p>0.05);而与 CAIS 和 CYP17A1 基因突变组的对照组女性相似(p>0.05)。作为男性抚养的儿童的 PSAI 评分高于作为女性抚养的 CAIS 和 CYP17A1 组(p<0.05)。CSRI 量表显示,46,XY DSD 患者与对照组之间的性别角色一致性和重新分配性别无统计学差异(p>0.05)。年龄≥8 岁的患者(n=44)均无性别焦虑症。
46,XY DSD 患者的重新分配性别与他们幼儿期的性别角色一致。他们都没有性别焦虑症。在我们的中国队列中,分子诊断、性腺功能和性别重新分配是一致的。还需要进行长期随访和更多评估。